3.3(top 10%)
impact factor
4.1K(top 5%)
176.6K(top 2%)
160(top 2%)
3.3(top 10%)
extended IF
all documents
doc citations
264(top 2%)

Top Articles

1Biological roles of oligosaccharides: all of the theories are correctGlycobiology19935,114
2Biological roles of glycansGlycobiology20171,676
3New insights on trehalose: a multifunctional moleculeGlycobiology20031,577
4Human milk oligosaccharides: Every baby needs a sugar mamaGlycobiology20121,315
5Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bondsGlycobiology20021,210
6History of lectins: from hemagglutinins to biological recognition moleculesGlycobiology2004882
7A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweedsGlycobiology2007844
8Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sitesGlycobiology2005825
9Symbol Nomenclature for Graphical Representations of GlycansGlycobiology2015818
10Fucose: biosynthesis and biological function in mammalsGlycobiology2003770
11Galectin-1: a small protein with major functionsGlycobiology2006742
12Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammationGlycobiology2005692
13Control of mucin-type O-glycosylation: A classification of the polypeptide GalNAc-transferase gene familyGlycobiology2012670
14Sulfated fucans, fresh perspectives: structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharideGlycobiology2003659
15Glycosidase inhibitors: update and perspectives on practical useGlycobiology2003644
16Optimal and consistent protein glycosylation in mammalian cell cultureGlycobiology2009595
17Diversity in the sialic acidsGlycobiology1992578
18Structures and mechanisms of glycosyltransferasesGlycobiology2006572
19Amino-sugar glycosidase inhibitors: versatile tools for glycobiologistsGlycobiology1992523
20The family of metazoan metal-independent β-galactoside-binding lectins: structure, function and molecular evolutionGlycobiology1993496
21Siglecs—the major subfamily of I-type lectinsGlycobiology2006490
22An evolving view of the eukaryotic oligosaccharyltransferaseGlycobiology2006469
23Evolutionary considerations in relating oligosaccharide diversity to biological functionGlycobiology1999465
24Formation of the glycan chains in the synthesis of bacterial peptidoglycanGlycobiology2001434
25All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferasesGlycobiology2003428
26Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2Glycobiology2020420
27Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeuticsGlycobiology2000417
28High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humansGlycobiology2011411
29Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutininGlycobiology2004409
30Invited Commentary: A calculation of all possible oligosaccharide isomers both branched and linear yields 1.05 × 1012 structures for a reducing hexasaccharide: the Isomer Barrier to development of single-method saccharide sequencing or synthesis systemsGlycobiology1994407
31Brain extracellular matrixGlycobiology1996405
32Dermatan sulfate: new functions from an old glycosaminoglycanGlycobiology2002397
33Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and foldingGlycobiology2003391
34Comparison of the methods for profiling glycoprotein glycans—HUPO Human Disease Glycomics/Proteome Initiative multi-institutional studyGlycobiology2007382
35Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseasesGlycobiology2002378
36MINI REVIEW Keratan sulfate: structure, biosynthesis, and functionGlycobiology2000373
37Ovarian Cancer is Associated with Changes in Glycosylation in Both Acute-Phase Proteins and IgGGlycobiology2007369
38Polysialylation: from bacteria to brainsGlycobiology1992366
39Sialic acids in cancer biology and immunityGlycobiology2016364
40Nod factor structures, responses, and perception during initiation of nodule developmentGlycobiology2002363
41Fucosylation in prokaryotes and eukaryotesGlycobiology2006359
42N-Glycans in cancer progressionGlycobiology2008358
43Lectin-like proteins in model organisms: implications for evolution of carbohydrate-binding activityGlycobiology2001355
44Plant protein glycosylationGlycobiology2016353
45Fc glycans of therapeutic antibodies as critical quality attributesGlycobiology2015346
46Focus on antivirally active sulfated polysaccharides: From structure–activity analysis to clinical evaluationGlycobiology2009344
47Fucosylated human milk oligosaccharides vary between individuals and over the course of lactationGlycobiology2001341
48CAZymes Analysis Toolkit (CAT): Web service for searching and analyzing carbohydrate-active enzymes in a newly sequenced organism using CAZy databaseGlycobiology2010335
49Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex typesGlycobiology2007334
50Mycobacterial lipoarabinomannan: An extraordinary lipoheteroglycan with profound physiological effectsGlycobiology1998333